MEDIA COVERAGE
After 2 undisclosed gene therapy deaths, can China’s alternative regulatory path still be trusted? 2026-08-17 Fierce Pharma
Why China’s biotech rise is harder to contain than AI? 2026-08-05, ThinkChina
Analysis of China-to-West pharmaceutical licensing deals in 2024 2025-04-09 in Nature Reviews Drug Discovery
中国Biotech崛起，威胁到美国了吗？2025-03-16 in PharmaDJ
自免新药，出海要趁早 2024-07-26 in Blue View (深蓝观)
For Chinese biotechs, the out-licensing business is scorching hot. Could geopolitics rain on their parade? 2024-04-11 in Fierce Biotech
Cover Story: Chinese Pharma Turns to Global Deals to Cure Capital Crunch 2024-02-26 by Caixin Global
Cover Story: The Miracle and Mirage of Weight Loss Drugs 2023-11-06 by Caixin Global
The BCMA frenzy: Tracking the 37 drugs around the world racing to overtake bluebird bio and Celgene 2019-05-02 by Endpoints News